Table 5. Comparison of groups due to tumor characteristics.
| Variable | Group 1 | Group 2 | p-value |
|---|---|---|---|
| No. of patients | 2,079 | 260 | - |
| Stage | 0.207 | ||
| Ta/Papilloma | 432 (30.2) | 56 (34.4) | |
| T1 | 496 (34.7) | 61 (37.4) | |
| T2 or higher | 502 (35.1) | 46 (28.2) | |
| Grade | 0.621 | ||
| 1 | 379 (30.9) | 42 (32.5) | |
| 2 | 415 (33.8) | 47 (36.5) | |
| 3 | 433 (35.3) | 40 (31.0) | |
| Size (cm) | 0.825 | ||
| <3 | 367 (29.8) | 45 (31.7) | |
| ≥3 | 829 (67.2) | 92 (64.8) | |
| Number | 0.356 | ||
| Solitary | 877 (63.8) | 109 (69.0) | |
| Multiple | 460 (33.5) | 44 (27.8) | |
| CIS | 0.710 | ||
| Negative | 1,242 (94.5) | 153 (95.6) | |
| Positive | 72 (5.5) | 7 (4.4) | |
| Type | 0.242 | ||
| Papilloma | 799 (67.1) | 97 (72.4) | |
| Solitary | 392 (32.9) | 37 (27.6) |
Values are presented as number (%).
Group 1, urothelial cancer (UC) patients without multiple primary cancer (MPC); group 2, UC patients with MPC; CIS, carsinoma in situ.